TNX-717

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTNX-717
Drug Alias Nameosteoblast apoptosis inhibitors (Tanox)TNX-717
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone synthesis modulatorsApoptosis inhibitors
TargetsUpdating
Therapy Area/IndicationsFractures, BoneOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTanox Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTanox Inc
Active IndicationsN/A
Inactive IndicationsFractures, BoneOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A